[Acer] (Correction) Board Approves Spin-off of Biomedical Business Unit to Establish 100% Owned Subsidiary

Acer announced a correction regarding its board's resolution to spin off its biomedical laboratory operations into a newly established, 100% owned subsidiary tentatively named Acer Biomedical Inc. The estimated business value to be transferred is NT$2 million, which Acer will exchange for 200,000 newly issued common shares at NT$10 per share. Transferred assets amount to NT$8.298 million and liabilities to NT$6.298 million. The spin-off aims to foster internal innovation and facilitate future strategic partnerships. The tentative record date for the spin-off is set for June 29, 2026.